Report an accessibility problem

RFP for Improving Care for Patients with Hodgkin and Non-Hodgkin’s Lymphoma

External Deadline:
Opportunity Information:

Pfizer has issued a request for proposals for improving care for patients with Hodgkin and non-Hodgkin’s lymphoma.

Grants expected to range from $20,000 to $200,000 will be awarded in support of efforts to identify and address the educational needs, barriers, and gaps for patients with Hodgkin lymphoma, T-cell lymphoma, and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) R/R DLBCL relating to treatments, management of adverse events, and long-term outcomes.

Proposed activities should focus on increasing clinicians’ knowledge, confidence, competence, and practice changes in caring for patients. This may include interactive learning, case-based learning, workshops, tumor boards, digital platforms, building communities of practice, and other live programs.

The estimated total available budget related to this RFP is $1.5 million.

To be eligible, applicants must be located in the United States. The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

For complete program guidelines and application instructions, see the Pfizer website.

ASU Information:

Submissions to this sponsor/donor are managed by the Office of Corporate and Foundation Relations. Please contact your unit-assigned ASUF Director of Development or Research Advancement Specialist at your earliest convenience to ensure ASU's strategic coordination and management of funding applications.

Posted Date: